different glp-1 Which works best? New meta-study puts them head-to-head The GLP-1 Agonists and Obesity:

Pfannkuche A et al, Prevalence and risk factors of diabetic peripheral neuropathy in a diabetics cohort: Register initiative diabetes and nerves

from the University of Arizona

Fibroblast growth factorbased pharmacotherapies for the treatment of obesity-related metabolic complications

In their paper on the study, published in JAMA Ophthalmology , the researchers noted that the substantially increased risk of NAION observed in patients on semaglutide appears not to be due to differences in baseline characteristics between the cohorts. They proposed the possibility that expression of the GLP-1 receptor in the human optic nerve and GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION. Another notable finding was that the greatest risk of NAION appeared to be within the first year following the prescription of semaglutide, a temporal association that supports a potential drug-induced risk of NAION, the researchers pointed out

Frequency Injectable: The set it and forget it nature of the weekly shot appeals to those who dont want to think about medication every day

What Does Join Polly Offer